Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 108 Total
BNED - Barnes & Noble Education Inc - Stock Price Chart
TickerBNED [NYSE]
CompanyBarnes & Noble Education Inc
CountryUSA
IndustrySpecialty Retail
Market Cap10.55MEPS (ttm)-1.56
P/E-EPS this Y47.93%
Forward P/E-EPS next Y46.47%
PEG-EPS past 5Y18.50%
P/S0.01EPS next 5Y20.00%
P/B0.11EPS Q/Q61.93%
Dividend-Sales Q/Q2.15%
Insider Own30.76%Inst Own33.43%
Insider Trans0.00%Inst Trans-3.22%
Short Float3.89%EarningsMar 12/a
Analyst Recom3.00Target Price0.75
Avg Volume867.01K52W Range0.52 - 2.26
Barnes and Noble Education, Inc. engages in the management and operation of bookstore chains in universities. It operates through the following segments: Retail, Wholesale, and Digital Student Solutions (DSS). The Retail segment operates physical and virtual campus bookstores. The Wholesale segment sells hardware and software that provides inventory management and point-of-sale solutions to college bookstores. The DSS segment includes direct-to-student product and service offerings to assist students to study more effectively and improve academic performance. The company was founded by Leonard Riggio in 1965 and is headquartered in Basking Ridge, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHAR JONATHANEVP, RetailSep 22 '23Option Exercise0.0079,2690186,682Sep 26 04:43 PM
MILLER MICHAEL CONNOLLYCLO, EVP, Corp Aff & SecretarySep 22 '23Option Exercise0.0060,9760210,482Sep 26 04:41 PM
Paul SeemaSVP, Chief Accounting OfficerSep 22 '23Option Exercise0.0016,9380137,597Sep 26 04:42 PM
HUSEBY MICHAELCEOSep 22 '23Option Exercise0.00223,57801,199,988Sep 26 04:40 PM
MOTS - Motus GI Holdings Inc - Stock Price Chart
TickerMOTS [NASD]
CompanyMotus GI Holdings Inc
CountryUSA
IndustryMedical Devices
Market Cap0.63MEPS (ttm)-28.52
P/E-EPS this Y-10.51%
Forward P/E-EPS next Y-
PEG-EPS past 5Y48.56%
P/S1.95EPS next 5Y-
P/B0.07EPS Q/Q62.32%
Dividend-Sales Q/Q-41.28%
Insider Own1.10%Inst Own4.71%
Insider Trans0.00%Inst Trans-
Short Float0.45%EarningsMar 18/a
Analyst Recom1.00Target Price8.30
Avg Volume1.67M52W Range0.16 - 23.40
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company was founded in 2008 and is headquartered in Fort Lauderdale, FL.
PACB - Pacific Biosciences of California Inc - Stock Price Chart
TickerPACB [NASD, RUT]
CompanyPacific Biosciences of California Inc
CountryUSA
IndustryMedical Devices
Market Cap519.82MEPS (ttm)-1.21
P/E-EPS this Y15.19%
Forward P/E-EPS next Y17.08%
PEG-EPS past 5Y-9.76%
P/S2.59EPS next 5Y-1.00%
P/B0.74EPS Q/Q17.69%
Dividend-Sales Q/Q113.35%
Insider Own6.08%Inst Own98.34%
Insider Trans-1.23%Inst Trans-6.40%
Short Float19.49%EarningsFeb 15/a
Analyst Recom1.79Target Price9.62
Avg Volume8.25M52W Range2.81 - 14.55
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORDONEZ KATHYDirectorMar 15 '24Option Exercise2.87361,6211,038,682380,216Mar 19 04:24 PM
Meline David WDirectorMar 06 '24Buy4.4040,000176,16040,000Mar 06 05:36 PM
HENRY CHRISTIAN OSee RemarksMar 04 '24Sale4.8714,17769,0562,596,670Mar 06 05:12 PM
Van Oene MarkSee RemarksMar 04 '24Sale4.879,18644,7451,668,826Mar 06 05:26 PM
Kim Susan G.See RemarksMar 04 '24Sale4.875,27525,695712,260Mar 06 05:22 PM
CLDI - Calidi Biotherapeutics Inc - Stock Price Chart
TickerCLDI [AMEX]
CompanyCalidi Biotherapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap9.48MEPS (ttm)-1.03
P/E-EPS this Y45.66%
Forward P/E-EPS next Y32.98%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q11.53%
Dividend-Sales Q/Q-
Insider Own42.13%Inst Own5.71%
Insider Trans0.00%Inst Trans-86.27%
Short Float0.72%EarningsMar 15/a
Analyst Recom1.50Target Price3.25
Avg Volume410.08K52W Range0.38 - 13.79
Today 08:31AM Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering (Business Wire) -55.52%
Apr-09-24 07:00AM Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Companys Novel Immunotherapies at the AACR Annual Meeting 2024 (Business Wire) +62.39%
Mar-15-24 04:05PM Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results (Business Wire)
Mar-11-24 07:00AM Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer (Business Wire)
Feb-12-24 07:00AM Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference (Business Wire)
Jan-08-24 07:00AM Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board (Business Wire) +6.84%
Dec-13-23 07:00AM Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit (Business Wire)
Dec-12-23 07:00AM Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directors (Business Wire)
Nov-20-23 07:00AM Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones (Business Wire)
Nov-14-23 04:05PM Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results (Business Wire) -6.98%
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
PRFX - PainReform Ltd - Stock Price Chart
TickerPRFX [NASD]
CompanyPainReform Ltd
CountryIsrael
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.29MEPS (ttm)-7.65
P/E-EPS this Y28.29%
Forward P/E-EPS next Y25.78%
PEG-EPS past 5Y-28.81%
P/S-EPS next 5Y-
P/B0.18EPS Q/Q-17.35%
Dividend-Sales Q/Q-
Insider Own25.22%Inst Own10.88%
Insider Trans0.00%Inst Trans1.30%
Short Float1.27%EarningsMar 01/b
Analyst Recom1.00Target Price11.00
Avg Volume125.76K52W Range0.98 - 26.41
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
DRMA - Dermata Therapeutics Inc - Stock Price Chart
TickerDRMA [NASD]
CompanyDermata Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.71MEPS (ttm)-3.98
P/E-EPS this Y48.31%
Forward P/E-EPS next Y52.17%
PEG-EPS past 5Y26.37%
P/S-EPS next 5Y-
P/B0.16EPS Q/Q74.96%
Dividend-Sales Q/Q-
Insider Own6.04%Inst Own4.59%
Insider Trans0.00%Inst Trans-85.55%
Short Float1.63%EarningsMar 22/b
Analyst Recom1.00Target Price1.50
Avg Volume140.97K52W Range0.30 - 3.93
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
KXIN - Kaixin Holdings. - Stock Price Chart
TickerKXIN [NASD]
CompanyKaixin Holdings.
CountryChina
IndustryAuto & Truck Dealerships
Market Cap3.60MEPS (ttm)-0.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.05EPS next 5Y-
P/B1.09EPS Q/Q-100.00%
Dividend-Sales Q/Q-
Insider Own17.88%Inst Own1.16%
Insider Trans0.00%Inst Trans-36.15%
Short Float0.57%Earnings-
Analyst Recom-Target Price-
Avg Volume964.91K52W Range0.15 - 6.66
Kaixin Holdings operates as a holding company, which engages in the sale of automobiles through its subsidiaries. The company was founded in 2015 and is headquartered in Beijing, China.
RVYL - Ryvyl Inc - Stock Price Chart
TickerRVYL [NASD]
CompanyRyvyl Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap9.30MEPS (ttm)-9.89
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-51.16%
P/S0.14EPS next 5Y-
P/B0.40EPS Q/Q-16.59%
Dividend-Sales Q/Q113.56%
Insider Own69.06%Inst Own5.74%
Insider Trans0.00%Inst Trans-74.34%
Short Float1.91%EarningsMar 26/a
Analyst Recom1.00Target Price25.00
Avg Volume27.74K52W Range1.57 - 17.50
Ryvyl, Inc. operates as a financial technology company, which develops, markets, and sells innovative block chain-based payment solutions. It operates through the North America and International geographical segments. The company was founded in 2007 and is headquartered in San Diego, CA.
WOOF - Petco Health and Wellness Co Inc - Stock Price Chart
TickerWOOF [NASD]
CompanyPetco Health and Wellness Co Inc
CountryUSA
IndustrySpecialty Retail
Market Cap432.27MEPS (ttm)-4.78
P/E-EPS this Y-155.01%
Forward P/E20.52EPS next Y257.79%
PEG-EPS past 5Y-25.03%
P/S0.07EPS next 5Y48.80%
P/B0.36EPS Q/Q-168.35%
Dividend-Sales Q/Q6.12%
Insider Own48.04%Inst Own56.26%
Insider Trans0.02%Inst Trans-6.99%
Short Float18.03%EarningsMar 13/b
Analyst Recom2.67Target Price2.77
Avg Volume3.81M52W Range1.64 - 10.76
Petco Health & Wellness Company, Inc. engages in the provision of pet health and wellness services. It operates across the U.S., Mexico and Puerto Rico, including a growing network, store veterinary hospitals, and offer a complete online resource for pet health and wellness. The firm offers grooming, as well as in-store and online training. The company was founded in 1965 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRIGGS GARY SDirectorDec 01 '23Buy3.3330,00099,92470,085Dec 04 07:29 PM
ALLR - Allarity Therapeutics Inc - Stock Price Chart
TickerALLR [NASD]
CompanyAllarity Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap0.88MEPS (ttm)-4117.54
P/E-EPS this Y86.06%
Forward P/E-EPS next Y-6.29%
PEG-EPS past 5Y57.56%
P/S-EPS next 5Y-
P/B-EPS Q/Q99.91%
Dividend-Sales Q/Q-
Insider Own10.59%Inst Own0.62%
Insider Trans0.00%Inst Trans-
Short Float6.01%EarningsMar 08/b
Analyst Recom1.00Target Price8.00
Avg Volume424.29K52W Range1.93 - 2520.00
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.
1234561011